Dimensional Fund Advisors LP Liquidia Corp Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$6.27 - $8.15 $22,716 - $29,527	-3,623 Reduced 6.39%	53,103 $336,000
Q1 2023 May 12, 2023	SELL	$5.72 - $7.91 $40,268 - $55,686	-7,040 Reduced 11.04%	56,726 $391,000
Q4 2022 Feb 09, 2023	BUY	$4.68 - $6.54 $56 - $78	12 Added 0.02%	63,766 $406,000
Q2 2022 Aug 12, 2022	SELL	$3.37 - $7.55 $35,563 - $79,675	-10,553 Reduced 14.2%	63,754 $278,000
Q1 2022 May 13, 2022	BUY	$5.14 - $7.38 $138,307 - $198,581	26,908 Added 56.77%	74,307 $534,000
Q4 2021 Feb 09, 2022	BUY	$2.71 - $5.17 $96,305 - $183,726	35,537 Added 299.59%	47,399 $231,000
Q3 2021 Nov 12, 2021	SELL	$2.28 - $2.95 $10,608 - $13,726	-4,653 Reduced 28.17%	11,862 $33,000
Q2 2021 Aug 12, 2021	BUY	$2.51 - $3.11 $41,452 - $51,361	16,515 New	16,515 $47,000

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.